Compare Salesforce Inc (CRM) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Salesforce Inc vs McKesson Corporation — how do they compare? Salesforce Inc trades at $194.68 (market cap $158.33B), while McKesson Corporation trades at $867.65 (market cap $102.45B). The key difference: Salesforce Inc is the larger of the two by market cap, and Salesforce Inc pays the higher dividend (0.91%). Which is the better fit depends on your goals.
| CRM | MCK | |
|---|---|---|
Market Cap | $158.33B | $102.45B |
Sector | Technology | Health |
52-Week High | $266.23 | $995.69 |
52-Week Low | $150.12 | $663.17 |
Enterprise Value | $188.38B | $108.99B |
Dividend Yield | 0.91% | 0.43% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Salesforce (CRM) trades at $195.88, down 0.81% on the day amid broader tech sector volatility. The stock shows strong fundamentals with consistent earnings beats, including Q1 2026 EPS of $3.88 beating expectations of $3.13. Technical indicators are bullish overall, with moving averages signaling strength while oscillators remain neutral. Revenue growth continues at $37.9B for 2025, with profit margins expanding to 16.35%.
Salesforce presents a compelling investment case with 76% analyst buy ratings and a $231.91 consensus price target representing 18% upside. Key risks include AI-driven software sector volatility and competitive pressures, but strong cash flow generation and improving profitability support long-term growth prospects.
McKesson (MCK) trades at $877.87, down 0.23% on the day, with strong technical momentum indicated by bullish moving averages and ADX signals. The company reported robust Q1 2027 results with EPS of $9.93 beating estimates by 20% year-over-year, driven by specialty drug growth and oncology performance. Revenue reached $105.4 billion, up 8%, prompting management to raise full-year adjusted EPS guidance. Analyst consensus remains strongly bullish with 24 buy ratings and a $990.67 price target, representing 13% upside potential.
MCK presents a compelling investment case with consistent earnings beats, raised guidance, and strong operational cash flow of $6.9 billion projected for 2026. Key risks include margin pressure from the low 1.12% net income margin, high accounts payable of $55.33 billion, and negative shareholder equity of -$2.07 billion. The stock's valuation at 24.19 P/E appears reasonable given growth prospects, but investors should monitor debt levels and pharmaceutical pricing dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Salesforce Inc
Salesforce Inc provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.
Read more on CRM →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
